Description Of Progressivity And Prognosis In Lung Cancer Patients In Rsud. Dr. H. Abdul Moeloek Lampung, 2018-2021
DOI:
https://doi.org/10.53089/medula.v12i2.366Keywords:
Kanker paru, Progresivitas, Stadium keganasan, Komorbid, Komplikasi, Prognosis.Abstract
Lung cancer is all malignancy that occurs in the lung and originates from the lung itself (primary) and can even occur from outside the lung (metastasis). 2. Smoking is the highest risk factor for lung cancer. In general, the early stages do not cause prominent complaints, but over time general complaints can be seen. 3. Many lung cancer patients are diagnosed at stage III and IV so that the life expectancy is lower. This study aims to determine the frequency distribution of pulmonary CA patients in hospitals. DR. H. Abdul Moeloek Lampung Province in 2018-2021 with quantitative descriptive research methods. Lung cancer patients were male (73.8%) and female (26.2%) mostly aged 35-65 (70.9%), without a family history of lung cancer (77.9%), had a history of lung cancer. smoking (75.0%), found in stage IV B (37.7%), stage IV A (37.3%), stage III B (15.6%) and stage III A (15.6%). Most lung cancer patients were found without comorbid (41.8%), accompanied by complications of pleural effusion (35.2%) with contralateral lung metastases (32.8%). Most local metastases are found in the contralateral lung and distant metastases are often found in the brain. Early detection is important because the speed of treatment greatly affects the prognosis of the disease.
References
Joseph J, Rotty LWA. Kanker Paru : Laporan Kasus. 2020;2(1):17-25.
Febriani A, Furqon A. Metastasis Kanker Paru. 2018;4(3):94-101.
Rejeki M, Pratiwi E. Diagnosis dan Prognosis Kanker Paru, Probabilitas Metastasis dan Upaya Prevensinya. Proceeding of The URECOL. 2020:73-78.
Wiguna PDA, Saputra H, Dewi IGASM. DIAGNOSIS SITOLOGI PASIEN DENGAN DIAGNOSIS KLINIS TUMOR PARU BERDASARKAN BERBAGAI METODE PENGAMBILAN SAMPEL SITOLOGI DI RSUP SANGLAH TAHUN 2014-2018. 2021;10(2):33-39.
Dinkes. Dinas Kesehatan Ajak Masyarakat Waspadai Kanker. Dinas Kesehatan Provinsi Lampung.
Iqbalawaty I, Machillah N, Farjriah F, et al. Profil hasil pemeriksaan CT-Scan pada pasien tumor paru di Bagian Radiologi RSUD Dr. Zainoel Abidin periode Juli 2018-Oktober 2018. Intisari Sains Medis. 2019;10(3):625-630. doi:10.15562/ism.v10i3.661
Chairudin MR, Marhana IA, Erawati D. Profil Pasien Kanker Paru Primer yang Dirawat Inap dan Rawat Jalan di Rumah Sakit Umum Daerah Dr Soetomo Surabaya. 2019;5(3):65-71.
Myrnasari RS, Astuti T, Pratiwi SD, Pulmonologi D, Fakultas R, Universitas K. Studi Pendahuluan : Profil Peningkatan Kadar PAI-1 pada Pasien Kanker Paru yang Mendapat Kemoterapi Preliminary Study : Increased Profile of PAI-1 in Lung Cancer Patients Receiving Chemotherapy. 2017;38(1):48-56.
Nabila SF, Setiawan D, Putra H, et al. J-REMI : Jurnal Rekam Medik Dan Informasi Kesehatan ANALISIS FAKTOR RISIKO PADA PENYAKIT KARSINOMA PARU ( C34 ) PASIEN RAWAT INAP DI RUMAH SAKIT J-REMI : Jurnal Rekam Medik Dan Informasi Kesehatan. 2021;2(2):244-254.
Megasari A, Bagiada M. Ketahanan hidup 1 tahun karsinoma paru di divisi Pulmonologi RSUP Sanglah Denpasar. Medicina (B Aires). 2020;51(1):1-5. doi:10.15562/medicina.v51i1.323
Dutkowska AE, Antczak A. Comorbidities in lung cancer. Adv Respir Med. 2016;84(3):186-192. doi:10.5603/PiAP.2016.0022
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Medical Profession Journal of Lampung
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
